WOLFGANG WINKELMAYER to Cardiovascular Agents
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Cardiovascular Agents.
Connection Strength
1.857
-
Use of secondary prevention medications among adults with reduced kidney function. Clin J Am Soc Nephrol. 2012 Apr; 7(4):604-11.
Score: 0.367
-
Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010 Oct; 88(4):548-54.
Score: 0.332
-
Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008 Sep; 3(5):1415-22.
Score: 0.286
-
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008 Apr 01; 51(13):1247-54.
Score: 0.281
-
Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. Am J Cardiol. 2007 Oct 01; 100(7):1061-7.
Score: 0.268
-
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis. 2006 Feb; 47(2):301-8.
Score: 0.242
-
Medication issues in older individuals with CKD. Adv Chronic Kidney Dis. 2010 Jul; 17(4):320-8.
Score: 0.082